Wealthspire Advisors (New York)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $876K | Sell |
6,921
-4,105
| -37% | -$519K | ﹤0.01% | 417 |
|
|
2025
Q1 | $1.41M | Sell |
11,026
-814
| -7% | -$104K | 0.01% | 325 |
|
|
2024
Q4 | $1.57M | Sell |
11,840
-4,243
| -26% | -$561K | 0.02% | 286 |
|
|
2024
Q3 | $2.34M | Buy |
16,083
+2,343
| +17% | +$341K | 0.02% | 226 |
|
|
2024
Q2 | $1.89M | Hold |
13,740
| – | – | 0.02% | 213 |
|
|
2024
Q1 | $1.89M | Sell |
13,740
-3,585
| -21% | -$492K | 0.03% | 209 |
|
|
2023
Q4 | $2.35M | Buy |
17,325
+44
| +0.3% | +$5.98K | 0.03% | 171 |
|
|
2023
Q3 | $2.11M | Buy |
17,281
+214
| +1% | +$26.2K | 0.03% | 163 |
|
|
2023
Q2 | $2.17M | Sell |
17,067
-312
| -2% | -$39.6K | 0.04% | 148 |
|
|
2023
Q1 | $2.24M | Buy |
17,379
+288
| +2% | +$37.2K | 0.04% | 138 |
|
|
2022
Q4 | $2.24M | Sell |
17,091
-395
| -2% | -$51.9K | 0.04% | 141 |
|
|
2022
Q3 | $2.05M | Buy |
17,486
+3,933
| +29% | +$460K | 0.04% | 141 |
|
|
2022
Q2 | $1.59M | Sell |
13,553
-1,996
| -13% | -$235K | 0.03% | 160 |
|
|
2022
Q1 | $2.03M | Sell |
15,549
-4,896
| -24% | -$638K | 0.05% | 123 |
|
|
2021
Q4 | $3.12M | Sell |
20,445
-1,020
| -5% | -$156K | 0.07% | 105 |
|
|
2021
Q3 | $3.47M | Buy |
21,465
+870
| +4% | +$141K | 0.07% | 113 |
|
|
2021
Q2 | $3.37M | Buy |
20,595
+794
| +4% | +$130K | 0.09% | 80 |
|
|
2021
Q1 | $2.98M | Buy |
19,801
+458
| +2% | +$69K | 0.07% | 129 |
|
|
2020
Q4 | $2.93M | Buy |
19,343
+9,857
| +104% | +$1.49M | 0.09% | 103 |
|
|
2020
Q3 | $1.28M | Buy |
+9,486
| New | +$1.28M | 0.08% | 109 |
|
|
2020
Q2 | – | Sell |
-10,107
| Closed | -$1.09M | – | 388 |
|
|
2020
Q1 | $1.09M | Buy |
+10,107
| New | +$1.09M | 0.05% | 181 |
|
|
2019
Q1 | – | Sell |
-327
| Closed | -$32K | – | 387 |
|
|
2018
Q4 | $32K | Buy |
+327
| New | +$32K | ﹤0.01% | 246 |
|